This study is not accepting new patients

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

a study on Prostate Cancer

Summary

Eligibility
for males ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
Principal Investigator
by Thomas Hope, MD
Headshot of Thomas Hope
Thomas Hope

Description

Summary

This expanded access protocol provides eligible participants with investigational 68Ga-PSMA-11 PET imaging to detect and localize prostate cancer for initial and subsequent treatment strategy.

Official Title

Expanded Access: 68Gallium-PSMA-11 for PET Imaging of Prostate Cancer

Keywords

Prostate Cancer, Prostate, Prostate Adenocarcinoma, Prostatic Neoplasms, 68Gallium-PSMA-11, Positron Emission Tomography (PET)

Eligibility

For males ages 18 years and up

Biochemical recurrent and pre-prostatectomy staging participants will be eligible and must meet the following criteria:

Inclusion Criteria:

  1. Age ≥ 18 years
  2. Histopathologically confirmed or biopsy proven prostate adenocarcinoma.
  3. Concern for metastatic disease in one of the following settings:
    1. Initial staging with intermediate to high risk prostate cancer.
    2. Biochemical recurrence after initial therapy.
  4. Ability to understand a written informed consent document, and the willingness to sign it

Exclusion Criteria:

  1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation

Location

  • UCSF
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Thomas Hope, MD
    Thomas Hope, MD, is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology. He also serves as the Director of Molecular Therapy. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center and as chair of the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee.

Details

Status
not accepting new patients
Start Date
Sponsor
University of California, San Francisco
ID
NCT04377152
Study Type
Expanded Access
Last Updated